Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives.
D000328:Adult; D000924:Anticholesteremic Agents / Q000494:pharmacology; D001797:Blood Protein Electrophoresis; D002715:Chlormadinone Acetate / Q000009:adverse effects*; D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D008071:Lipoprotein Lipase / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D008656:Mestranol / Q000009:adverse effects*; D008875:Middle Aged; D014280:Triglycerides / Q000096:biosynthesis / Q000097:blood*
D000924:Anticholesteremic Agents; D003276:Contraceptives, Oral; D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D014280:Triglycerides; D002715:Chlormadinone Acetate; D002784:Cholesterol; D008656:Mestranol; D008071:Lipoprotein Lipase